Google+ Badge

Wednesday, December 16, 2015

Cancer Research:Survival rates for patients with prostate cancer better ♦ Preoperative use of blood-thinning drugs is safe for cancer patients ♦ Study uncovers hard-to-detect cancer mutations

Study uncovers hard-to-detect cancer mutations Current approaches to genome analysis systematically miss detecting a certain type of complex mutation in cancer patients' tumors, new research shows. Further, a significant percentage of these complex mutations are found in well-known cancer genes that could be targeted by existing drugs, potentially expanding the number of cancer patients who may benefit.
Experimental drugs that change energy supply in cells could slow brain tumor growth Experimental drugs that alter cell metabolism also halted tumor growth and extended survival in mice with cancers linked to changes in the same gene.
Preoperative use of blood-thinning drugs is safe for cancer patients Among patients undergoing major cancer operations, the preoperative use of blood-thinning drugs such as heparin does not increase rates of major bleeding or transfusions, and is associated with a decreased risk of blood clots.
Survival rates for patients with prostate cancer better with surgery versus radiotherapy A rigorous evaluation of survival rates has shown that cancer patients with localised prostate cancer -- the most common form of prostate cancer -- have a better chance of survival if treated by surgery than by radiotherapy. This is the most robust analysis (meta-analysis) to date of published literature comparing surgery and radiotherapy for localized prostate cancer

No comments:

Post a Comment